Assa Oumie
Avacta (United Kingdom)(GB)
Publications by Year
Research Areas
Cancer Genomics and Diagnostics, Molecular Biology Techniques and Applications, Monoclonal and Polyclonal Antibodies Research, Radiomics and Machine Learning in Medical Imaging, Colorectal Cancer Treatments and Studies
Most-Cited Works
- → HER2 overexpression and amplification as a potential therapeutic target in colorectal cancer: analysis of 3256 patients enrolled in the QUASAR, FOCUS and PICCOLO colorectal cancer trials(2015)234 cited
- → Genomic complexity of urothelial bladder cancer revealed in urinary cfDNA(2016)129 cited
- → Cross-laboratory validation of the OncoScan® FFPE Assay, a multiplex tool for whole genome tumour profiling(2015)90 cited
- → Comparing mutation calls in fixed tumour samples between the affymetrix OncoScan® array and PCR based next-generation sequencing(2017)12 cited
- → Abstract 4108: Preclinical evaluation of half-life extended Affimer® biotherapeutics targeting the PD-L1 pathway(2019)1 cited
- → Abstract 626: Cross-site reproducibility and orthogonal validation of copy number and somatic mutation calls of OncoScan® FFPE Assay Kit in solid tumors(2015)
- AffymetrixオンコスキャンアレイとPCRに基づく次世代シークエンシングとの間の固定腫瘍試料における突然変異鳴き声の比較【JST・京大機械翻訳】(2017)
- → Additional file 1: of Comparing mutation calls in fixed tumour samples between the affymetrix OncoScanÂŽ array and PCR based next-generation sequencing(2017)
- Comparison of Mutational Calls Obtained with Pyrosequencing and the Affymetrix OncoScan (R) FFPE Assay in Patients with Colon Cancer Recruited to the NCRI FOxTROT Trial(2015)
- → Additional file 2: of Comparing mutation calls in fixed tumour samples between the affymetrix OncoScan® array and PCR based next-generation sequencing(2017)